Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRCP | P42785 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25862310 | 0.91 | CYP19A1 (0.37) | PRCPCYP19A1 | |
| SCHEMBL19391070 | 0.84 | CYP19A1 (0.34) | PRCPCYP19A1 | |
| SCHEMBL20331946 | 0.83 | CYP19A1 (0.33) | PRCPCYP19A1 | |
| SCHEMBL20733344 | 0.83 | CYP19A1 (0.33) | PRCPCYP19A1 | |
| SCHEMBL20332541 | 0.83 | CYP19A1 (0.33) | PRCPCYP19A1 | |
| SCHEMBL21533087 | 0.83 | CYP19A1 (0.33) | PRCPCYP19A1 | |
| SCHEMBL20739051 | 0.83 | CYP19A1 (0.33) | PRCPCYP19A1 | |
| SCHEMBL22064639 | 0.83 | CYP19A1 (0.33) | PRCPCYP19A1 | |
| SCHEMBL19391281 | 0.83 | CYP19A1 (0.33) | PRCPCYP19A1 | |
| SCHEMBL25993221 | 0.82 | CYP19A1 (0.32) | CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230220001-A1 | METHOD FOR SYNTHESIS OF THIOETHER-CONTAINING PEPTIDES | HEIDELBERG PHARMA RESEARCH GMBH (DE) | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230220001-A1 | METHOD FOR SYNTHESIS OF THIOETHER-CONTAINING PEPTIDES | TST, PTMS, CTH | PRCP 588/4885CYP19A1 3060/4885EPHX2 1757/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.